Prognostic factors in prostate cancer

A Buhmeida, S Pyrhönen, M Laato, Y Collan - Diagnostic pathology, 2006 - Springer
Prognostic factors in organ confined prostate cancer will reflect survival after surgical radical
prostatectomy. Gleason score, tumour volume, surgical margins and Ki-67 index have the …

[PDF][PDF] The emergence of DNA methylation as a key modulator of aberrant cell death in prostate cancer

TM Murphy, AS Perry, M Lawler - Endocrine-Related Cancer, 2008 - researchgate.net
It is now well established that cancer cells exhibit a number of genetic defects in the
machinery that governs programmed cell death and that sabotage of apoptosis is one of the …

Interplay between two hormone-independent activation domains in the androgen receptor

L Callewaert, N Van Tilborgh, F Claessens - Cancer research, 2006 - AACR
The androgen receptor (AR) plays a key role in prostate cancer development, as well as its
treatments, even for the hormone-refractory state. Here, we report that an earlier described …

ASAP1, a Gene at 8q24, Is Associated with Prostate Cancer Metastasis

D Lin, A Watahiki, J Bayani, F Zhang, L Liu, V Ling… - Cancer research, 2008 - AACR
Metastatic prostate cancer is a terminal disease, and the development of reliable prognostic
tools and more effective therapy is critically important for improved disease survival and …

Demethyltransferase FTO alpha-ketoglutarate dependent dioxygenase (FTO) regulates the proliferation, migration, invasion and tumor growth of prostate cancer by …

S Li, L Cao - Bioengineered, 2022 - Taylor & Francis
ABSTRACT N6-Methyladenosine (m6A) is the most abundant modifications in human
messenger RNAs (mRNAs). This study aimed at investigating the function and mechanism …

IGHG1 regulates prostate cancer growth via the MEK/ERK/c‐Myc pathway

J Chu, Y Li, Z Deng, Z Zhang, Q Xie… - BioMed Research …, 2019 - Wiley Online Library
Increasing evidence indicates that immunoglobulins are important for the regulation of
various cancers including prostate cancer (PCa). However, the underlying mechanisms of …

Genetic Polymorphisms of GSTM1, GSTT1, and GSTP1 with Prostate Cancer Risk: A Meta-Analysis of 57 Studies

M Gong, W Dong, Z Shi, Y Xu, W Ni, R An - Plos one, 2012 - journals.plos.org
Background and Objectives The GSTM1, GSTT1 and GSTP1 polymorphisms might be
involved in inactivation of procarcinogens that contribute to the genesis and progression of …

Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression

S Kamdar, R Isserlin, T Van der Kwast, AR Zlotta… - Clinical …, 2019 - Springer
Background Global DNA methylation alterations are hallmarks of cancer. The tumor-
suppressive TET enzymes, which are involved in DNA demethylation, are decreased in …

Effects of AG490 and S3I‑201 on regulation of the JAK/STAT3 signaling pathway in relation to angiogenesis in TRAIL‑resistant prostate cancer cells in vitro

V Gurbuz, E Konac, N Varol, A Yilmaz… - Oncology …, 2014 - spandidos-publications.com
The aim of the present study was to analyze the molecular mechanisms involved in blocking
the signaling pathway and the effects of this on the progression of prostate cancer (CaP) …

microRNA-339-5p modulates Na+/I− symporter-mediated radioiodide uptake

A Lakshmanan, A Wojcicka, M Kotlarek… - Endocrine-Related …, 2015 - erc.bioscientifica.com
Na+/I− symporter (NIS)-mediated radioiodide uptake (RAIU) serves as the basis for targeted
ablation of thyroid cancer remnants. However, many patients with thyroid cancer have …